Fertility Test Market by Product (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Testing Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), and End User (Home Care Settings and Hospitals/Fertility Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2028
- ALL4621683
- 220 Pages
- May 2021
- Medical Devices
The global fertility testing market was valued at $462.23 million in 2020, and is projected to reach $842.96 million by 2028, registering a CAGR of 7.8%. This market growth is attributed to rise in the prevalence of diseases such as PCOS because women with the condition of PCOS do not ovulate every month regularly due to the overproduction of estrogen by the ovaries. Furthermore, increase in number of first-time pregnancies in women and decline in fertility rates across the globe drive the market growth. In addition, growth in awareness regarding fertility testing in both developed and developing countries boosts the market growth. Moreover, the launch of technologically advanced products with high accuracy further drives the market during the forecast period. For instance, in June 2020, Modern Fertility has launched its two new products, Modern Fertility Pregnancy Test, Ovulation Test and free Modern Fertility App.
On the other hand, shift in preference of patients toward at-home fertility tests, owing to availability of easy-to-use ovulation prediction test kits and surge in market strategies such as product development and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.
The global fertility test market is segmented on the basis of the product, mode of purchase, application, end user, and region. By product, the market is categorized into ovulation prediction kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further divided into urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. By mode of purchase, it is bifurcated into OTC-based and prescription-based. By application, it is fragmented into female fertility testing and male fertility testing. By end user, it is bifurcated into home care settings and fertility clinics. Region wise the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2021 to 2028, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysis market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Product
o Ovulation Prediction Kits
o Fertility Monitors
Urine-based Ovulation Kits
Saliva-based Ovulation Kit
Other Fertility Monitors
o Male Fertility Testing Products
By Mode of Purchase
o OTC-based
o Prescription-based
By Application
o Female Fertility Testing
o Male Fertility Testing
By End User
o Home Care Settings
o Fertility Clinics
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
• Church & Dwight Co. Inc.
• Fairhaven Health LLC
• Fertility Focus Limited
• Geratherm Medical AG
• HiLin Life Products Inc.
• Prestige Brands Holdings Inc.
• Quidel Corporation
• Abbott Laboratories
• UEBE Medical
• Advacare Pharma
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Declining fertility rates across the globe
3.5.1.2.Increasing awareness of fertility testing
3.5.1.3.Launch of technologically advanced products with high accuracy
3.5.2.Restraint
3.5.2.1.Unproven accuracy of ovulation monitors in PCOS/PCOD patients
3.5.2.2.High cost of fertility testing monitors
3.5.3.Opportunities
3.5.3.1.Sales of fertility testing devices on online platform
3.5.3.2.Growth opportunities in emerging countries
3.5.4.Impact analysis
3.6.COVID-19 Impact Analysis on fertility test Market
CHAPTER 4:FERTILITY TEST MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Ovulation Prediction Kits
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Fertility monitors
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.5.Urine based ovulation kits
4.3.5.1.Market size and forecast
4.3.6.Saliva based ovulation kits
4.3.6.1.Market size and forecast
4.3.7.Other fertility monitors
4.3.7.1.Market size and forecast
4.4.Male fertility testing products
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:FERTILITY TEST MARKET, BY MODE OF PURCHASE
5.1.Overview
5.1.1.Market size and forecast
5.2.OTC based fertility test
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Prescription based fertility test
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:FERTILITY TEST MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Female fertility testing
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Male fertility testing
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
CHAPTER 7:FERTILITY TEST MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. Fertility Test Market, by product
7.2.2.1.2.U.S. Fertility Test market, by application
7.2.2.1.3.U.S. Fertility Test Market, by distribution channel
7.2.2.2.Canada
7.2.2.2.1.Canada Fertility Test Market, by product
7.2.2.2.2.Canada Fertility Test Market, by application
7.2.2.2.3.Canada Fertility Test Market, by distribution channel
7.2.2.3.Mexico
7.2.2.3.1.Mexico Fertility Test Market, by product
7.2.2.3.2.Mexico Fertility Test Market, by application
7.2.2.3.3.Mexico Fertility Test Market, by distribution channel
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by distribution channel
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany Fertility Test Market, by product
7.3.2.1.2.Germany Fertility Test Market, by application
7.3.2.1.3.Germany Fertility Test Market, by distribution channel
7.3.2.2.France
7.3.2.2.1.France Fertility Test Market, by product
7.3.2.2.2.France Fertility Test Market, by application
7.3.2.2.3.France Fertility Test Market, by distribution channel
7.3.2.3.UK
7.3.2.3.1.UK Fertility Test Market, by product
7.3.2.3.2.UK Fertility Test Market, by application
7.3.2.3.3.UK Fertility Test Market, by distribution channel
7.3.2.4.Italy
7.3.2.4.1.Italy Fertility Test Market, by product
7.3.2.4.2.Italy Fertility Test Market, by application
7.3.2.4.3.Italy Fertility Test Market, by distribution channel
7.3.2.5.Spain
7.3.2.5.1.Spain Fertility Test Market, by product
7.3.2.5.2.Spain Fertility Test Market, by application
7.3.2.5.3.Spain Fertility Test Market, by distribution channel
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe Fertility Test Market, by product
7.3.2.6.2.Rest of Europe Fertility Test Market, by application
7.3.2.6.3.Rest of Europe Fertility Test Market, by distribution channel
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by distribution channel
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan Fertility Test Market, by product
7.4.2.1.2.Japan Fertility Test Market, by application
7.4.2.1.3.Japan Fertility Test Market, by distribution channel
7.4.2.2.China
7.4.2.2.1.China Fertility Test Market, by product
7.4.2.2.2.China Fertility Test Market, by application
7.4.2.2.3.China Fertility Test Market, by distribution channel
7.4.2.3.Australia
7.4.2.3.1.Australia Fertility Test Market, by product
7.4.2.3.2.Australia Fertility Test Market, by application
7.4.2.3.3.Australia Fertility Test Market, by distribution channel
7.4.2.4.India
7.4.2.4.1.India Fertility Test Market, by product
7.4.2.4.2.India Fertility Test Market, by application
7.4.2.4.3.India Fertility Test Market, by distribution channel
7.4.2.5.South Korea
7.4.2.5.1.South Korea Fertility Test Market, by product
7.4.2.5.2.South Korea Fertility Test Market, by application
7.4.2.5.3.South Korea Fertility Test Market, by distribution channel
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific Fertility Test Market, by product
7.4.2.6.2.Rest of Asia-Pacific Fertility Test Market, by application
7.4.2.6.3.Rest of Asia-Pacific Fertility Test Market, by distribution channel
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by distribution channel
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil Fertility Test Market, by product
7.5.2.1.2.Brazil Fertility Test Market, by application
7.5.2.1.3.Brazil Fertility Test Market, by distribution channel
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia Fertility Test Market, by product
7.5.2.2.2.Saudi Arabia Fertility Test Market, by application
7.5.2.2.3.Saudi Arabia Fertility Test Market, by distribution channel
7.5.2.3.South Africa
7.5.2.3.1.South Africa Fertility Test Market, by product
7.5.2.3.2.South Africa Fertility Test Market, by application
7.5.2.3.3.South Africa Fertility Test Market, by distribution channel
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA Fertility Test Market, by product
7.5.2.4.2.Rest of LAMEA Fertility Test Market, by application
7.5.2.4.3.Rest of LAMEA Fertility Test Market, by distribution channel
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by distribution channel
CHAPTER 8:COMPANY PROFILES
8.1.Church & Dwight Co., Inc.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.Fairhaven Health LLC
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.Fertility Focus Limited
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.Geratherm Medical AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.Hilin Life Products Inc.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.5.4.Business performance
8.5.5.Key strategic moves and developments
8.6.Prestige Consumer Healthcare Inc. (Prestige Brands Holdings Inc.)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.Quidel Corporation
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.Abbott Laboratories
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.UEBE Medical
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.9.4.Business performance
8.9.5.Key strategic moves and developments
8.10.AdvaCare Pharma
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
TABLE 01.GLOBAL FERTILITY TEST MARKET, BY PRODUCT, 2020–2028 ($MILLION)
TABLE 02.FERTILITY TEST MARKET FOR OVULATION PREDICTION KITS, BY REGION, 2020–2028 ($MILLION)
TABLE 03.FERTILITY TEST MARKET FOR FERTILITY MONITORS, BY REGION, 2020–2028 ($MILLION)
TABLE 04.FERTILITY TEST MARKET FOR FERTILITY MONITORS, BY TYPE, 2020–2028, ($MILLION)
TABLE 05.FERTILITY TEST MARKET FOR MALE FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 06.GLOBAL FERTILITY TEST MARKET, BY MODE OF PURCHASE, 2020–2028 ($MILLION)
TABLE 07.FERTILITY TEST MARKET FOR OTC BASED FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 08.FERTILITY TEST MARKET FOR PRESCRIPTION BASED FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 09.GLOBAL FERTILITY TEST MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 10.FERTILITY TEST MARKET FOR FEMALE FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 11.FERTILITY TEST MARKET FOR MALE FERTILITY TEST, BY REGION, 2020–2028 ($MILLION)
TABLE 12.FERTILITY TEST MARKET, BY REGION, 2020-2028 ($MILLION)
TABLE 13.NORTH AMERICA FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 14.U.S. FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 15.U.S. FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 16.U.S. FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 17.CANADA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 18.CANADA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 19.CANADA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 20.MEXICO FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 21.MEXICO FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 22.MEXICO FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 23.NORTH AMERICA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 24.NORTH AMERICA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 25.NORTH AMERICA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 26.EUROPE FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 27.GERMANY FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 28.GERMANY FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 29.GERMANY FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 30.FRANCE FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 31.FRANCE FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 32.FRANCE FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 33.UK FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 34.UK FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 35.UK FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 36.ITALY FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 37.ITALY FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 38.ITALY FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 39.SPAIN FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 40.SPAIN FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 41.SPAIN FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 42.REST OF EUROPE FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 43.REST OF EUROPE FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 44.REST OF EUROPE FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 45.EUROPE FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 46.EUROPE FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 47.EUROPE FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 48.ASIA-PACIFIC FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 49.JAPAN FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 50.JAPAN FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 51.JAPAN FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 52.CHINA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 53.CHINA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 54.CHINA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 55.AUSTRALIA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 56.AUSTRALIA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 57.AUSTRALIA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 58.INDIA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 59.INDIA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 60.INDIA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 61.SOUTH KOREA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 62.SOUTH KOREA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 63.SOUTH KOREA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 64.REST OF ASIA-PACIFIC FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 67.ASIA-PACIFIC FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 68.ASIA-PACIFIC FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 69.ASIA-PACIFIC FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 70.LAMEA FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 71.LAMEA FERTILITY TEST MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 72.BRAZIL FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 73.BRAZIL FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 74.BRAZIL FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 75.SAUDI ARABIA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 76.SAUDI ARABIA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 77.SAUDI ARABIA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 78.SOUTH AFRICA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 79.SOUTH AFRICA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 80.SOUTH AFRICA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 81.REST OF LAMEA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 82.REST OF LAMEA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 83.REST OF LAMEA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 84.LAMEA FERTILITY TEST MARKET, BY PRODUCT, 2020-2028 ($MILLION)
TABLE 85.LAMEA FERTILITY TEST MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 86.LAMEA FERTILITY TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 ($MILLION)
TABLE 87.CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT
TABLE 88.CHURCH & DWIGHT CO., INC.: OPERATING SEGMENTS
TABLE 89.CHURCH & DWIGHT CO., INC.: PRODUCT PORTFOLIO
TABLE 90.CHURCH & DWIGHT CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91.FAIRHAVEN HEALTH LLC: COMPANY SNAPSHOT
TABLE 92.FAIRHAVEN HEALTH LLC: OPERATING SEGMENTS
TABLE 93.FAIRHAVEN HEALTH LLC: PRODUCT PORTFOLIO
TABLE 94.FAIRHAVEN HEALTH LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.FERTILITY FOCUS LIMITED: COMPANY SNAPSHOT
TABLE 96.FERTILITY FOCUS LIMITED: OPERATING SEGMENTS
TABLE 97.FERTILITY FOCUS LIMITED: PRODUCT PORTFOLIO
TABLE 98.FERTILITY FOCUS LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99.GERATHERM MEDICAL AG: COMPANY SNAPSHOT
TABLE 100.GERATHERM MEDICAL AG: OPERATING SEGMENTS
TABLE 101.GERATHERM MEDICAL AG: PRODUCT PORTFOLIO
TABLE 102.GERATHERM MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.HILIN LIFE PRODUCTS INC: COMPANY SNAPSHOT
TABLE 104.HILIN LIFE PRODUCTS INC: PRODUCT PORTFOLIO
TABLE 105.HILIN LIFE PRODUCTS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106.PRESTIGE CONSUMER HEALTHCARE INC: COMPANY SNAPSHOT
TABLE 107.PRESTIGE CONSUMER HEALTHCARE INC: OPERATING SEGMENTS
TABLE 108.PRESTIGE CONSUMER HEALTHCARE INC: PRODUCT PORTFOLIO
TABLE 109.PRESTIGE CONSUMER HEALTHCARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110.QUIDEL CORPORATION: COMPANY SNAPSHOT
TABLE 111.QUIDEL CORPORATION: OPERATING SEGMENTS
TABLE 112.QUIDEL CORPORATION: PRODUCT PORTFOLIO
TABLE 113.QUIDEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 115.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 116.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 117.ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118.UEBE MEDICAL: COMPANY SNAPSHOT
TABLE 119.UEBE MEDICAL: PRODUCT PORTFOLIO
TABLE 120.UEBE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.ADVACARE PHARMA: COMPANY SNAPSHOT
TABLE 122.ADVACARE PHARMA: OPERATING SEGMENTS
TABLE 123.ADVACARE PHARMA: PRODUCT PORTFOLIO
TABLE 124.ADVACARE PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
